rs17853166

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003640.5(ELP1):​c.751A>G​(p.Ser251Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0212 in 1,612,468 control chromosomes in the GnomAD database, including 452 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 30 hom., cov: 32)
Exomes 𝑓: 0.022 ( 422 hom. )

Consequence

ELP1
NM_003640.5 missense

Scores

1
7
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 3.58

Publications

12 publications found
Variant links:
Genes affected
ELP1 (HGNC:5959): (elongator acetyltransferase complex subunit 1) The protein encoded by this gene is a scaffold protein and a regulator for three different kinases involved in proinflammatory signaling. The encoded protein can bind NF-kappa-B-inducing kinase and I-kappa-B kinases through separate domains and assemble them into an active kinase complex. Mutations in this gene have been associated with familial dysautonomia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
ELP1 Gene-Disease associations (from GenCC):
  • primary dysautonomia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Riley-Day syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012105852).
BP6
Variant 9-108917660-T-C is Benign according to our data. Variant chr9-108917660-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 137569.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.016 (2405/150776) while in subpopulation NFE AF = 0.0248 (1678/67570). AF 95% confidence interval is 0.0238. There are 30 homozygotes in GnomAd4. There are 1175 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 30 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELP1NM_003640.5 linkc.751A>G p.Ser251Gly missense_variant Exon 9 of 37 ENST00000374647.10 NP_003631.2 O95163Q4LE38Q8N516
ELP1NM_001318360.2 linkc.409A>G p.Ser137Gly missense_variant Exon 9 of 37 NP_001305289.1 O95163A0A6Q8PGW3B4E3I9
ELP1XM_047423991.1 linkc.751A>G p.Ser251Gly missense_variant Exon 9 of 25 XP_047279947.1
ELP1NM_001330749.2 linkc.-297A>G 5_prime_UTR_variant Exon 7 of 35 NP_001317678.1 F5H2T0B3KNB2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELP1ENST00000374647.10 linkc.751A>G p.Ser251Gly missense_variant Exon 9 of 37 1 NM_003640.5 ENSP00000363779.5 O95163

Frequencies

GnomAD3 genomes
AF:
0.0160
AC:
2404
AN:
150658
Hom.:
30
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00437
Gnomad AMI
AF:
0.0132
Gnomad AMR
AF:
0.0119
Gnomad ASJ
AF:
0.0119
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00795
Gnomad FIN
AF:
0.0239
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0248
Gnomad OTH
AF:
0.0116
GnomAD2 exomes
AF:
0.0176
AC:
4435
AN:
251482
AF XY:
0.0182
show subpopulations
Gnomad AFR exome
AF:
0.00449
Gnomad AMR exome
AF:
0.00630
Gnomad ASJ exome
AF:
0.0111
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0243
Gnomad NFE exome
AF:
0.0279
Gnomad OTH exome
AF:
0.0194
GnomAD4 exome
AF:
0.0218
AC:
31808
AN:
1461692
Hom.:
422
Cov.:
33
AF XY:
0.0211
AC XY:
15325
AN XY:
727164
show subpopulations
African (AFR)
AF:
0.00421
AC:
141
AN:
33480
American (AMR)
AF:
0.00631
AC:
282
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0123
AC:
321
AN:
26132
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39690
South Asian (SAS)
AF:
0.00747
AC:
644
AN:
86256
European-Finnish (FIN)
AF:
0.0238
AC:
1269
AN:
53412
Middle Eastern (MID)
AF:
0.0101
AC:
58
AN:
5768
European-Non Finnish (NFE)
AF:
0.0252
AC:
28032
AN:
1111840
Other (OTH)
AF:
0.0175
AC:
1056
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1505
3010
4515
6020
7525
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1002
2004
3006
4008
5010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0160
AC:
2405
AN:
150776
Hom.:
30
Cov.:
32
AF XY:
0.0160
AC XY:
1175
AN XY:
73656
show subpopulations
African (AFR)
AF:
0.00438
AC:
179
AN:
40876
American (AMR)
AF:
0.0119
AC:
180
AN:
15174
Ashkenazi Jewish (ASJ)
AF:
0.0119
AC:
41
AN:
3438
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5162
South Asian (SAS)
AF:
0.00796
AC:
38
AN:
4776
European-Finnish (FIN)
AF:
0.0239
AC:
251
AN:
10484
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0248
AC:
1678
AN:
67570
Other (OTH)
AF:
0.0115
AC:
24
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
119
239
358
478
597
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0218
Hom.:
230
Bravo
AF:
0.0145
TwinsUK
AF:
0.0227
AC:
84
ALSPAC
AF:
0.0270
AC:
104
ESP6500AA
AF:
0.00613
AC:
27
ESP6500EA
AF:
0.0227
AC:
195
ExAC
AF:
0.0188
AC:
2288
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.0239
EpiControl
AF:
0.0202

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial dysautonomia Benign:4
May 18, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:3
Mar 28, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 03, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.11
T
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.68
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-1.2
T
MutationAssessor
Pathogenic
3.3
M
PhyloP100
3.6
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-2.7
D
REVEL
Benign
0.21
Sift
Uncertain
0.016
D
Sift4G
Benign
0.11
T
Polyphen
0.95
P
Vest4
0.059
MPC
0.089
ClinPred
0.061
T
GERP RS
4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.20
gMVP
0.21
Mutation Taster
=79/21
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17853166; hg19: chr9-111679940; API